Tetanus

Neurology India

Volumn 50, Issue 4, 2002, Pages 398-407

  Bhatia, R ^a   Prabhakar, S ^a   Grover, V K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Lock jaw; Spasms; Tetanus

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTITOXIN; ATRACURIUM; BACLOFEN; BACTERIAL VACCINE; BENZODIAZEPINE DERIVATIVE; CISATRACURIUM; CLONIDINE; DANTROLENE; DIAZEPAM; DIPHTHERIA TOXOID; ESMOLOL; MAGNESIUM SULFATE; METRONIDAZOLE; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PENICILLIN G; PHENOTHIAZINE DERIVATIVE; PROPOFOL; PROPRANOLOL; ROCURONIUM; SEDATIVE AGENT; STEROID; TETANUS ANTIBODY; TETANUS TOXOID; TOXIN; UNINDEXED DRUG; VECURONIUM;

ATROPHY; BACTERIAL INFECTION; BRACHIAL PLEXUS; BRADYCARDIA; CLINICAL FEATURE; CLINICAL TRIAL; CLOSTRIDIUM TETANI; CULTURAL ANTHROPOLOGY; DEBRIDEMENT; DEVELOPING COUNTRY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE CONTROL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG PENETRATION; DRUG POTENTIATION; DYSAUTONOMIA; EMBOLISM; ERADICATION THERAPY; ERYTHEMA; GUILLAIN BARRE SYNDROME; HEALTH CARE MANAGEMENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; IMMOBILIZATION; IMMUNIZATION; INJECTION SITE; KIDNEY FAILURE; LACTIC ACIDOSIS; LUNG DISEASE; META ANALYSIS; MORTALITY; MUSCLE CONTRACTURE; NEUROPATHY; NEWBORN TETANUS; NONHUMAN; PAIN; PANCREAS DISEASE; PATHOGENESIS; PREGNANCY; PRESCRIPTION; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SKIN MANIFESTATION; SPORE GERMINATION; TACHYPHYLAXIS; TETANIC SPASM; TETANUS; TETANUS PROPHYLAXIS; TRISMUS; URTICARIA; VACCINATION; VEIN THROMBOSIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNIZATION; INCIDENCE; PREVENTIVE MEDICINE; TETANUS;

EID: 0037005395     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Hsu SS, Groleau G: Tetanus in the emergency department: A current review. J Emerg Med 2000; 20:357-365.
2. Farrar JJ, Yen LM, Cook T et al: Tetanus. J Neurol Neurosurg Psychiatry 2000; 69:292-301.
3. Benett J, Azhar N, Rahim F et al: Further, observations on ghee as a risk factor for neonatal tetanus. Int J Epidemiol 1995; 24:643-647.
4. Barderheier B, Prevots R, Khetsuriani N et al: CDC. Tetanus Surveillance - United States 1995-1997. MMWR 1998; 47 (SS2):1-13.
5. Lee HC, Ko WC, Chuang YC: Tetanus of the elderly. J Microbiol Immunol Infect 2000; 33:191-196.
6. Prabhakar S, Syal P: Tetanus. In: Tropical Neurology. Misra UK, Kalita, Shakir RA (eds.) Landee Biosciences. (In Press).
7. Bartlett JG: Tetanus. In: Cecil Textbook of Medicine, Goldman Lee, Bennett JC (eds). 21st Edition, Philadelphia: W.B. Saunders 2001; 1675-1677.
8. Bleck TP, Brauner JS: Tetanus. In: Infections of the Central Nervous System. Scheld WM, Whitely RJ, Durack DT (eds). 2nd edition. Philadelphia: Lipincott - Raven, 1997; 629-653.
9. Wright DK, Lalloo UG, Nayiager S et al: Autonomic nervous system dysfunction in severe tetanus: Current perspectives. Crit Care Med 1989; 17:371-375.
10. Domenighetti GM, Sarary G, Stricker H: Hyperadrenergic syndrome in severe tetanus: Extreme rise in catecholamines responsive to labetolol. BMJ 1984; 288:1483-1484.
11. Trujillo MH, Castillo A, Espana J et al: Impact of intensive care management on the prognosis of tetanus. Chest 1987; 92:63-65.
12. Cook TM, Protheoze RT, Handel JM: Tetanus: A review of literature. Br J Anaesth 2001; 87:477-87.
13. Toothill C, Dykes JRW, Ablett JJL: Urinary catecholamine metabolites concentration in tetanus. Br J Anaesth 1970; 42:524-530.
14. Kerr JH, Corbert JL, Pryst-Roberts C et al: Involvement of sympathetic nervous system in tetanus. Lancet 1968; 2:236-241.
15. Kakou AR, Eholic S, Ehui E et al: Localised tetanus in Abidjan: Clinical and prognostic features (1976-1997). Bull Soc Pathol Exot 2001; 94: 308-311.
16. Jagoda A, Riggio S, Burgieres T: Cephalic tetanus: A case report and review of literature. Am J Emerg Med 1988; 6:128-130.
17. Vakil BJ, Singhal BS, Pandya SS et al: Cephalic tetanus. Neurology 1973; 23:190-196.
18. Patel JC, Kale PA, Mehta BC: Otogenic tetanus - Study of 922 cases. In: Processing of an International Conference on Tetanus. Patle JC (ed). Bombay. 1965;640-644
19. Nida H: Neonatal tetanus in Awassa. Retrospective analysis of patients admitted over 5 years. Ethiop Med J 2001; 39: 241-246.
20. Phillips LA: A classification of tetanus. Lancet 1967; 1: 1216-1217.
21. Ablett JJL: Analysis and main experiences in 82 patients treated n the Tetanus unit. In: Symposium on tetanus in Great Britain. Ellis M (ed). Boston Spa, National Lending Library, U.K. 1967; 1-10.
22. Prabhakar S, Singh G, Chopra JS et al: Peripheral neuropathy in tetanus: A clinical, neuroelectrophysiological and histological evaluation. Neurol Ind 1997; 45: 81-86.
23. Apte NM, Karnad DR: Short report - The spatula test: A single bedside test to diagnose tetanus. Am J Trop Med Hyg 1995; 53: 386-387.
24. Dastur FD: Emergency treatment of tetanus. JAPI 1997; (Suppl 2) : 44-46.
25. Garlicki A, Caban J, Bociaga JM et al: Modifications in treatment of tetanus and prognosis: Observations from the Gacon Department of Infectious Diseases. Przegl Lek 1999; 56: 566-567.
26. Ahmadsyah J, Salim A: Treatment of tetanus: An open study to compare the efficacy of procaine penicillin and metronidazole. BMJ 1985; 291: 648-650.
27. Yen LM, Dao LM, Day NPJ et al: Management of tetanus: A comparison of penicillin and metronidazole. Symposium of Antimicrobial Resistance in Southern Vietnam. 1997.
28. Singhi S, Jain V, Subramanian C: Post-neonatal tetanus: Issues in intensive care management. Indian J Pediatr 2001; 68: 267-272.
29. Abrutyn E, Berlin JA: Intrathecal therapy in tetanus: A meta-analysis. JAMA 1991; 226: 2262-67.
30. Al-Kaabi JM, Scrimgeour EM, Louon A et al: Tetanus: A clinical review. Saudi Med J 2001; 22: 606-609.
31. Gyasi HK, Fahr J, Kurian et al: Midazolam for prolonged intravenous sedation in patients with tetanus. Middle East J Anesth 1993; 12: 135-141.
32. Tobias JD: Anesthetic implications of tetanus. South Med J 1998; 91: 384-87.
33. Jacobi J, Fraser GL, Coursin DB et al: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30: 117-141.
34. Borgeat A, Popovic V, Schwander D: Efficacy of a continuous infusion of propofol in a patient with tetanus. Crit Care Med 1991; 19: 295-297.
35. Doxacurium - Corticosteroid acute myopathy: Another piece to the puzzle. Crit Care Med 1996; 24: 1266-1267.
36. Murray MJ, Cowen J, DeBlock H et al: Clinical practice guidelines for sustained neuromuscular blockade in adult critically ill patients. Crit Care Med 2002; 30: 142-156.
37. Attygalle D, Rodrigo N: Magnesium sulfate for control of spasms in severe tetanus. Can we avoid sedation and artificial ventilation? Anaesthesia 1997; 52: 952-962.
38. Attagylle D, Rodrigo N: Magnesium sulfate for the control of spasms in severe tetanus. Anaesthesia 1999; 54: 302-303.
39. Blacke JA: The use of magnesium sulfate in the production of anaesthesia and in the treatment of tetanus. Surgical Gynaecology and Obstetrics 1906; 2: 541-550.
40. Engrand N, Vilain G, Rouamba A et al: Value of intrathecal baclofen in the treatment of severe tetanus in the tropical milieu. Med Trop 2000; 60: 385-388.
41. Boots RJ, Lipman J, O'Lallagan J et al: The treatment of tetanus with intrathecal baclofen. Anaesth Intensive Care 2000; 28: 438-442.
42. Engrand N, Van De Perre P et al: Intrathecal baclofen for severe tetanus in a pregnant woman. Eur J Anaesthesiol 2001; 18: 261-263.
43. Engrand N, Guerot E, Rouamba A et al: The efficacy of intrathecal baclofen in severe tetanus. Anesthesiology 1999; 90: 1773-1776.
44. Prys-Roberts C, Corbett JL, Kerr JH et al: Treatment of sympathetic overactivity in tetanus. Lancet 1969; 1: 542.
45. Rocke DA, Pather M, Calver AD et al: Morphine in tetanus - The management of sympathetic nervous system overactivity. S Afr Med J 1986; 70: 666-668
46. Bhagwanjee S, Bosenberg AT, Muckart DJT: Management of sympathetic overactivity in tetanus with epidural bupivacaine and sufentanil. Experience with 11 patients. Crit Care Med 1999; 27: 1721-1725.
47. Wesley AG, Hariprasad D, Pather M et al: Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia 1983; 38: 243-249.
48. Gregorakos L, Kerezoudi E, Dimopoulos G et al: Management of blood pressure instability in severe tetanus: The use of clonidine. Intensive Care Med 1997; 23: 893-894.
49. James MFM, Manson EDM: The use magnesium infusions in management of very severe tetanus. Intensive Care Medicine 1985; 11: 5-12.
50. Lipman J, James MFM, Esskire J et al: Autonomic dysfunction in severe tetanus: Magnesium sulfate as an adjuncive deep sedation. Crit Care Med 1987; 15: 987-988.
51. Halliday PL, Bauer RB: Polyradiculitis secondary to immunization with tetanus and diphtheria toxoids. Arch Neurol 1983; 40: 56-57.
52. Schwendeman SP, Tobio M, Joworonicz M et al: New strategies for the microencapsulation of tetanus vaccine. J Microencapsul 1998; 15: 299-318.
53. Grover VK, Gupta S, Sharma S et al: Management of tetanus: A review of 100 consecutive cases. J Anaesth Clin Pharmacol 1992; 10: 23-27.
54. Lau LG, Kong KO, Chew PH: A ten year retrospective study of tetanus at a general hospital in Malaysia. Singapore Med J 2001; 42: 346-350.